Skip to main content
HairCited

Terapia laser a bassa intensità per Alopecia femminile

A

Basato su 8 studi (1 meta-analysis, 2 RCTs) con 5,391 partecipanti totali. 7/8 studi mostrano effetti positivi.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'haircited.com'; const params = 'ingredient\u003Dlow\u002Dlevel\u002Dlaser\u0026condition\u003Dfemale\u002Dpattern\u002Dhair\u002Dloss'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

In sintesi

Low-level laser therapy has strong evidence for female pattern hair loss and represents one of the best-supported non-medication options available for women experiencing this condition.

  • 7 out of 8 studies report positive effects, including well-designed RCTs with sham controls
  • Especially relevant for women who may want to avoid oral medications
  • Included in international clinical guidelines for female pattern hair loss
  • Both clinical treatments and at-home devices have shown effectiveness in studies

Key Study Findings

randomized controlled trial n=9 12.5 weeks Single-blind
Photobiomodulation therapy and 5% minoxidil in female pattern hair loss: a case series focusing on …
Dose: Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil vs: Placebo Effetto: Both groups improved QoL and hair density; PBMt + MIN showed significantly greater reduction in telo None
Randomized Controlled Trial 24 weeks Single-blind
Comparative efficacy of 2% minoxidil alone against combination of 2% minoxidil and low-level laser therapy …
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: None

Randomized Controlled Trial
Comparison of low-level light therapy and combination therapy of 5% minoxidil in the treatment of …
Dose: 3 g vs: control Outcome: None Effetto: None P < 0.05

Popolazione: None

prospective interventional study (single-arm) n=20 16 weeks
Results of low-level laser therapy in the treatment of hair growth: An Egyptian experience.
Dose: 20 minutes, 2 sessions/week for 16 weeks (32 total sessions) vs: Placebo Effetto: FPHL: 222.3 to 255.3 hairs/cm² (p=0.007); TE: 271.2 to 294.2 hairs/cm² (p=0.143) 0.007 (FPHL); 0.143 (TE)
Review
Female pattern hair loss: A comprehensive review.
Dose: None vs: None Outcome: None Effetto: None None

Popolazione: Female pattern hair loss patients

Review 16 weeks
Examining the Safety and Efficacy of Low-Level Laser Therapy for Male and Female Pattern Hair …
Dose: Low-level laser therapy (LLLT), 600-1100 nm wavelength, treatment ≥16 weeks vs: Placebo Effetto: All 8 sham-controlled studies showed statistically significant increase in hair diameter or density p < 0.01 (all sham-device cont

Key Statistics

14

Studi

5537

Partecipanti

Positive

A

Grado

Referenced Papers

Dermatologic therapy 2020 48 citazioni
Lasers in medical … 2016 83 citazioni
The Cochrane database … 2016 18 citazioni

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosaggi di uso comune

hairloss:
8-15 minutes, 3x/week

Limite massimo: Not applicable

Dosaggi studiati nella ricerca

Dosaggio Durata Effetto N
Photobiomodulation therapy (PBMt; red laser 100mW, 4J/point, 25 sessions, twice weekly) + minoxidil 12.5 weeks Positive 9
None 24 weeks Positive --
3 g -- Positive --
20 minutes, 2 sessions/week for 16 weeks (32 total sessions) 16 weeks Positive 20
None -- Negative --
Low-level laser therapy (LLLT), 600-1100 nm wavelength, treatment ≥16 weeks 16 weeks Positive --
finasteride 1 mg/d, dutasteride 0.5 mg/d, topical minoxidil 5% twice daily (MPHL); topical minoxidil -- Positive --
None -- Mixed --

Momento migliore per l'assunzione: Use device for recommended duration 3 times per week on non-consecutive days

Safety & Side Effects

Effetti collaterali segnalati

  • Mild scalp warmth or tingling
  • Headache (uncommon)
  • Initial shedding phase (rare)
  • Dry scalp

Interazioni note

  • Photosensitizing medications (tetracyclines, fluoroquinolones) may increase scalp sensitivity
  • No significant interactions with oral hair loss medications

Livello di assunzione massimo tollerabile: Not applicable

Consultare sempre il proprio medico prima di iniziare qualsiasi integratore.Consultate sempre il vostro medico prima di iniziare qualsiasi integratore.

Frequently Asked Questions

Does Terapia laser a bassa intensità help with Alopecia femminile?
Based on 14 studies with 5,537 participants, there is strong evidence from multiple clinical trials that Terapia laser a bassa intensità may support Alopecia femminile management. Our evidence grade is A (Strong Evidence).
How much Terapia laser a bassa intensità should I take for Alopecia femminile?
Studies have used various dosages. A commonly studied range is 8-15 minutes, 3x/week. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Terapia laser a bassa intensità?
Reported side effects may include Mild scalp warmth or tingling, Headache (uncommon), Initial shedding phase (rare), Dry scalp. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Terapia laser a bassa intensità and Alopecia femminile?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 14 peer-reviewed studies with 5,537 total participants. The overall direction of effect is positive.

Related Evidence

Terapia laser a bassa intensità per altre condizioni

Avvertenza FDA: Queste affermazioni non sono state valutate dalla Food and Drug Administration. I prodotti e le informazioni presenti su questo sito web non sono destinati a diagnosticare, trattare, curare o prevenire alcuna malattia. I gradi di evidenza presentati si basano sulla nostra analisi della ricerca pubblicata e sottoposta a revisione paritaria e non costituiscono consulenza medica. Consultate sempre il vostro medico prima di iniziare qualsiasi regime di integrazione.